MYC and diffuse large B-cell lymphoma: We note also that the survival rate (68 %) observed for intermediate cases classified as DLBCL by BDC is not significantly different from that for DLBCL as a whole (Kaplan-Meier, p = 0.4 compared with the R-CHOP-treated DLBCLs without MYC rearrangement.